How Healthcare Buyers Research Vendors Today and What You Need to Do to Get Shortlisted

Your CRM Sees the Iceberg's Tip

Back in February, one of our clients, a MedTech company launching a new spinal implant, called me in a bit of a panic. Their pipeline had been dry for six weeks straight. Then, in the space of four days, three deals landed. Fully formed. Named champion, rough budget, timeline already discussed internally.

Nobody on their sales team could tell me where the deals came from.

We pulled the thread. All three surgical groups had read the same clinical outcomes article we'd placed. Two had visited the pricing page more than once. One stakeholder had asked an AI assistant to compare implant vendors by complication rate. None of that touched a CRM. None of it looked like a lead. It just quietly became three deals.

I don't think that story is unusual anymore. I think it's close to the median.

Most healthcare vendors still build marketing around what they can see: a form fill, a webinar registration, a demo request. Fair enough, that's the data we have. But the actual research almost never starts there.

A hospital operations director might spend three weeks reading quietly about discharge delays before anyone on her team touches a form. A practice administrator might text a former colleague, "who did you use for referral intake last year," long before your website analytics register a single visit from her IP address.

It's worth noting that even the federal government is wrestling with a version of this same visibility problem. CMS is building out a National Provider Directory as part of its Interoperability Framework, precisely because provider information across the system, who practices where, what they accept, how to reach them, decays and fragments faster than anyone tracking it wants to admit. If the federal government needs a live, constantly-updated directory just to keep basic provider facts straight, you can imagine what happens to a marketing database that gets touched twice a year.

That's a tangent I'll come back to. For now, the point is simpler: the buyer's path bounces between a Google search, an article, a vendor site, LinkedIn, sometimes an AI assistant, sometimes an internal Teams thread nobody outside the account will ever see. Then a cold email lands from a vendor already somewhere in that mix, and suddenly it doesn't feel cold at all.

I used to run inbound and outbound as two completely separate motions with two separate playbooks and, frankly, two separate budgets that fought each other every quarter. I don't do that anymore. The buyer experiences one journey. We're the ones who keep chopping it into channels for our own convenience.

Buyers Google the Problem Long Before They Google You

Nobody types "which patient engagement platform should we buy" into a search bar on day one. A revenue cycle director searches something closer to why prior authorization denials keep climbing. A commercial lead at a device company wants to know why orthopedic surgeons are slow on a new technique. The problem always shows up first. The category comes second. Your brand name comes a distant third, if it shows up at all.

I learned this one the hard way, early on, at a diagnostics company. We spent almost a full year publishing content entirely about our own platform: features, integrations, an award we'd won. Traffic held steady. Conversion was miserable, genuinely embarrassing in a board meeting. The quarter we pivoted to writing about the actual operational headaches our buyers were Googling instead, cost per lead fell by more than half. The product hadn't changed a single feature. The starting point of the conversation had.

What I'd tell a vendor doing this today

• Build content around the problem your buyer already has, not the category you've assigned yourself.
• If you sell patient engagement software, write about no-shows and fragmented intake before you write another word about your own platform.
• Pull actual language from sales call transcripts. Buyers don't talk the way your positioning deck talks.

Inbound Alone Will Leave Money on the Table

Here's the part that makes purely inbound strategies uncomfortable: the exact right buyer, with the exact problem you solve, may simply never find you. A competitor outranks you. A colleague recommends someone else first. An AI assistant lists three vendors in its answer and yours isn't one of them. Or, just as often, the problem hasn't gotten painful enough yet to trigger a search at all.

If your entire pipeline depends on someone stumbling into you, you've handed control of your growth to buyer timing and to search algorithms you don't own and can't audit.

This is where a defined, targeted list changes the math, and it's most of what we actually do at MedicalProspects. Not "we sell to hospitals." Something closer to: multi-location cardiology groups in the Southeast running three or more sites, or oncology practice administrators at organizations that added a service line in the past year. Once an audience is defined at that level of precision, it becomes the backbone for cold email, SDR calling, LinkedIn targeting, and account-based campaigns, not a static spreadsheet someone downloaded once and never touched again.

Say you're a pharmacy device manufacturer trying to reach independent pharmacies and the pharmacists who actually make the buying call. You don't need a generic "healthcare" list for that. You need the exact pharmacists at the exact pharmacy types you're built for, and you run campaigns straight at them instead of spraying a broad list and hoping something sticks.

Which brings me to something almost nobody talks about at conferences: the list decays under you while you're using it. A 2023 study published in Annals of Internal Medicine tracked national Medicare billing data and found physician turnover climbed from 5.3% to 7.6% a year between 2010 and 2018. That means roughly one in thirteen physician records in a purchased list is already wrong before your first send goes out, and the number only gets worse from there. We rebuild and re-verify contact data on a rolling basis for exactly this reason. A list that was accurate in January is not automatically accurate in September.

One Buyer, Five Channels, and an Attribution Report That Lies to You

Picture a practice administrator at a cardiology group. She finds your article on referral intake through an organic search and reads the whole thing without filling out a form. A week later, a LinkedIn post from your company shows up in her feed, unprompted. A colleague on her team gets a targeted email from your SDR the same week. Your paid campaign is already running against her organization because it's on your target account list. Then someone from your team calls the director of operations at the same practice.

By the time she lands back on your website, your name already feels familiar. Not new. Familiar.

Which channel gets the credit in your pipeline report? SEO? The LinkedIn post? The cold call that happened to land the same week? Pick one and you'll be wrong, because she never experienced a single channel. She experienced accumulation. One touch built recognition. Another built credibility. A third prompted the actual reply. Design for that instead of expecting one campaign to carry the entire decision on its own shoulders.

The Shortlist Is Often Closed Before Your Rep Opens Their Mouth

Forrester's Buyers Journey Survey, which polled more than eleven thousand B2B buyers, found that 92% start their evaluation with at least one vendor already in mind. Forty-one percent already have a single preferred vendor before formal evaluation even begins.

I sat in on a discovery call two years ago where the prospect, a hospital system's IT director, had already built a four-vendor comparison spreadsheet before our AE said a word. That call wasn't discovery. It was a test of whether we'd contradict anything she'd already concluded from our site and a case study she'd found on her own.

We passed, mostly by accident, because our website already said the same thing our AE said on the call. If your best differentiation only lives inside a sales deck, buyers may never see it before the shortlist locks. Your case studies, your LinkedIn presence, your website copy, and your rep's opening pitch all need to answer three questions the same way: does this vendor understand organizations like mine, do they understand my specific problem, and why should I pick them over the tab I have open next to this one.

Buyers Search in Their Language. Most Vendors Write in Theirs.

"AI-powered clinical intelligence platform" reads well in a board deck. It means almost nothing typed into a search bar at 9pm by a tired ops director. A cardiology administrator searches cardiology problems. A CIO searches integration and security questions. A revenue cycle leader searches denial reduction, never "end-to-end healthcare ecosystem."

Pull your actual sales call recordings if you want the real language. Not the positioning workshop from last year's offsite.

AI Assistants Are Now Part of the Vendor Shortlist

Buyers are asking AI assistants to summarize categories, compare vendors, and draft their evaluation questions before a rep ever gets a reply. G2 data cited in recent competitive intelligence analysis puts the share of buyers now starting software research inside an AI chatbot at 51%, a number that was close to a rounding error three years ago.

Even CMS is leaning into this. Its new Interoperability Framework explicitly names conversational AI assistants and digital intake tools as use cases it wants to see built on top of provider data, with an ambition CMS itself has described as trying to "kill the clipboard" in patient intake. If federal policy is being written around the assumption that AI will mediate more of the healthcare data experience, vendor marketing should assume the same thing. An AI system can only describe your company as clearly as your own site describes it. "We transform healthcare through innovation" gives an AI model nothing to work with. Say who you serve, which specialty, which problem, and what's actually different, in plain words, and treat AI visibility as one more research channel instead of a separate initiative with its own budget line.

It's a Buying Group, Not a Buyer

One of the more expensive mistakes I've made in this business was building an entire campaign around a single job title, the CIO, and assuming she alone would push a hospital technology deal through. It didn't work. It rarely does.

Recent analysis of Gartner and Forrester buying-group research puts the average B2B buying group at roughly 13 internal stakeholders and nine external participants, and separately, buyers now spend only about 17% of total buying time in direct contact with any vendor at all.

The person who finds you is rarely the person who replies. The person who replies is rarely in the demo. The person in the demo rarely controls budget. This is exactly why we build client lists around full buying groups at MedicalProspects, technical, clinical, financial, operational, rather than a single decision-maker contact, because a single email address was never going to carry an entire deal.

A health IT vendor selling an interoperability tool doesn't just need the CIO. They need the CIO, the informatics lead who'll actually run the integration, and the compliance officer who'll ask about data handling before anyone signs. Get a list built around all three roles at your target hospitals and your outreach starts landing in three inboxes at once instead of one, which is usually the difference between a deal that moves and one that stalls in committee.

Specialty-Level Precision Makes Every Channel Sharper

Healthcare is not one market, no matter how convenient that would be for a marketing calendar. A cardiologist and an orthopedic surgeon do not share priorities. A forty-location oncology group does not evaluate a new platform the way a two-doctor primary care clinic does.

Broad targeting produces broad messaging. Broad messaging quietly weakens every single channel it touches: your ads, your emails, your cold calls, your landing pages, all of it, at the same time, without anyone noticing until pipeline numbers come in soft.

Define your audience at the point where the buyer's actual problem changes. If your product solves something different for oncology than it does for cardiology, build two campaigns. Not one campaign with a find-and-replace on the specialty name.

A staffing company placing travel nurses doesn't need a generic list of "hospital contacts." They need nurse managers and unit directors at facilities with documented shortage patterns in the specialties they actually staff. Build the list around that level of specificity and the campaign practically writes itself, because you're finally talking to someone with the exact problem instead of someone who happens to work in a hospital.

Outbound Has to Earn Attention Before It Asks for a Meeting

Cold outreach still works. Irrelevant outreach is just far easier to ignore than it used to be, and buyers have gotten ruthless about filtering it out.

Gartner's research found that 73% of B2B buyers actively avoid vendors that send irrelevant outreach. That's not a rounding error. That's most of your addressable market opting out because the first message missed.

Compare "we help healthcare organizations improve efficiency, got 15 minutes?" against a message that names the exact operational problem multi-location cardiology groups face standardizing referral intake across sites. The second version has a shot, because the buyer may already be sitting with that exact headache. Build outbound from the audience backward: define the niche, build or refresh the list, segment by specialty and role, then let every channel reinforce whatever the prospect already saw somewhere else last week.

Stop Scoring Channels the Buyer Never Actually Experienced

SEO reports on organic traffic. Paid reports on conversions. SDRs report calls booked. Every team measures its own lane, dutifully, every Monday. The buyer never sees a single one of those lanes. She sees your company.

The better question isn't which channel deserves credit. It's whether the accounts you actually want to win are repeatedly running into relevant information while they're forming a preference. If your addressable market is a defined set of two thousand organizations, you should already know which ones are engaging, which stakeholders are responding, and which topics are generating interest, well before a single MQL shows up on a pipeline slide.

This is the part of the job MedicalProspects exists for. Whether you're a MedTech company trying to reach the specific surgeons who'd use your implant, a pharmacy device manufacturer trying to reach the pharmacists who make the buying call, or a health IT vendor trying to reach hospital IT directors at a defined bed-size range, we build and continuously refresh the exact buyer list for your category, by specialty, role, organization type, geography, and facility characteristics, so email outreach, SDR calling, LinkedIn targeting, and ABM programs all run off the same accurate foundation instead of five disconnected spreadsheets pulling in different directions.

Know Exactly Who You're Trying to Reach

You can publish a hundred articles, run a thousand ads, and make ten thousand calls. None of it compounds if you can't name, with real precision, the healthcare buyers and organizations you're actually trying to influence.

The modern healthcare buyer moves across ten channels before she ever talks to a rep. Your job was never to guess which one she'll use next. It's to know exactly who you're chasing and build enough honest, relevant touchpoints that by the time the shortlist gets built, you're already sitting on it.

---